IHC results found that TROY-expressing cells were detected in most HCC tumor tissues with expression percentage around 0–5%, while the expression of TROY is rarely detected in non-tumor tissues (Fig. 1D, 1E). This evidence concerns the gene TNFRSF19 and hepatocellular carcinoma.